<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
<meta name="Generator" content="Microsoft Word 15 (filtered medium)">
<!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
{font-family:Helvetica;
panose-1:2 11 6 4 2 2 2 2 2 4;}
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Solano-Gothic;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:#0563C1;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:#954F72;
text-decoration:underline;}
p
{mso-style-priority:99;
mso-margin-top-alt:auto;
margin-right:0in;
mso-margin-bottom-alt:auto;
margin-left:0in;
font-size:12.0pt;
font-family:"Times New Roman",serif;}
span.EmailStyle17
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:windowtext;}
span.EmailStyle19
{mso-style-type:personal-reply;
font-family:"Calibri",sans-serif;
color:#1F497D;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang="EN-US" link="#0563C1" vlink="#954F72">
<div class="WordSection1">
<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span style="font-size:12.0pt;font-family:"Helvetica",sans-serif;color:#1F497D">Can you imagine how much medicine could be safely disposed and they could brand the bins and be the
heroes for $100 million? They raised fees 50% on members to do a PR campaign instead of the right thing and pay for a take back program. This makes me want to fight even harder to make them pay.
<o:p></o:p></span></p>
<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span style="font-size:12.0pt;font-family:"Helvetica",sans-serif;color:#1F497D">Heidi<o:p></o:p></span></p>
<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span style="font-size:12.0pt;font-family:"Helvetica",sans-serif;color:#1F497D">************************************************************************************************************<o:p></o:p></span></p>
<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span style="font-size:12.0pt;font-family:"Helvetica",sans-serif;color:#0A0A0A"><a href="http://fortune.com/2017/01/24/phrma-go-boldly-pr-campaign/">http://fortune.com/2017/01/24/phrma-go-boldly-pr-campaign/</a>
<o:p></o:p></span></p>
<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span style="font-size:12.0pt;font-family:"Helvetica",sans-serif;color:#0A0A0A">The justification for the campaign is clear: For more than a year, politicians seeking the presidency
have been slamming the likes of Martin Shkreli and Valeant Pharmaceuticals <a href="http://fortune.com/company/vrx">
<span style="font-size:13.0pt;font-family:Solano-Gothic;color:black;text-transform:uppercase;text-decoration:none">(vrx)</span></a> for outrageous price hikes on old and niche drugs. And while drug makers originally thought that President Donald Trump would
be a far more enthusiastic partner, <a href="http://fortune.com/2017/01/13/trump-drug-prices-death-panels/" target="_blank">
<span style="color:#1BAAE1;text-decoration:none">he said that drug makers</span></a> are "getting away with murder" during his first major post-New Year press conference. Trump went on to insist that his administration will chase direct negotiations and bidding
in Medicare as a way to keep drug prices in check - a policy that PhRMA vehemently opposes.<o:p></o:p></span></p>
<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span style="font-size:12.0pt;font-family:"Helvetica",sans-serif;color:#0A0A0A">During an
<a href="http://video.cnbc.com/gallery/?video=3000586636" target="_blank"><span style="color:#1BAAE1;text-decoration:none">appearance on CNBC</span></a> Monday, Ubl said that there was too much focus on people in "hoodies" (a reference to Shkreli's irreverent
and nonchalant style) and not enough on those "in lab coats" who are developing life-saving therapies.<o:p></o:p></span></p>
<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span style="font-size:12.0pt;font-family:"Helvetica",sans-serif;color:#0A0A0A">PhRMA has been preparing this PR onslaught for a while, too. Right before the presidential election,
the group <a href="http://fortune.com/2016/10/26/brainstorm-health-daily-10-26/" target="_blank">
<span style="color:#1BAAE1;text-decoration:none">hiked its membership dues</span></a> by 50%, helping it raise another $100 million per year to be funneled into pro-pharma campaigns. The lobbying outfit also successfully defeated one of the most high-profile
drug price cap referenda in the country in California's Proposition 61. The <a href="http://fortune.com/2016/10/26/brainstorm-health-daily-10-26/" target="_blank">
<span style="color:#1BAAE1;text-decoration:none">measure failed handily</span></a> in a deep blue state despite initially polling well thanks, in large part, to the pharmaceutical industry's $110 million spending spree to defeat it.<o:p></o:p></span></p>
<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span style="font-size:12.0pt;font-family:"Helvetica",sans-serif;color:#0A0A0A">Whether the latest campaign will be as successful is still an open question. Trump has already said
that drug price bidding will become a reality despite drug makers' considerable political and financial clout; but Congress may not be nearly as eager as the new president, especially in the wake of this upcoming lobbying blitz.<o:p></o:p></span></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal" style="background:white"><b><span style="font-size:13.0pt;color:#221D4D">Heidi Sanborn
</span></b><b><span style="font-size:13.0pt;font-family:"Arial",sans-serif;color:#221D4D">|</span></b><b><span style="font-size:13.0pt;color:#221D4D"> Executive Director</span></b><span style="font-size:13.0pt;color:#221D4D"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:black"><img border="0" width="240" height="90" id="Picture_x0020_1" src="cid:image001.jpg@01D297E0.504D2FF0" alt="CPSC logo 750px"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:#31005A"> O: (916) 706-3420 </span><span style="font-size:13.0pt;font-family:"Arial",sans-serif;color:#221D4D">|</span><span style="font-size:13.0pt;color:#221D4D">
</span><span style="color:#31005A">C: (916) 402-3911<o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="color:#31005A"> </span>
</b><u><span style="color:#31005A"><a href="mailto:heidi@calpsc.org">heidi@calpsc.org</a></span></u><span style="color:#31005A">
<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:2.0pt;color:#002060"><o:p> </o:p></span></p>
<p class="MsoNormal"><b><span style="color:black"> </span></b><a href="https://www.facebook.com/CaliforniaPSC" target="_blank"><span style="color:#1F497D;text-decoration:none"><img border="0" width="27" height="26" id="Picture_x0020_2" src="cid:image002.jpg@01D297E0.504D2FF0" alt="fb"></span></a><span style="color:#1F497D"> </span><a href="https://twitter.com/CalPSC"><span style="color:#1F497D;text-decoration:none"><img border="0" width="27" height="28" id="Picture_x0020_3" src="cid:image003.jpg@01D297E0.504D2FF0" alt="even smaller"></span></a><span style="color:#1F497D"> </span><a href="https://www.linkedin.com/company/california-product-stewardship-council"><span style="color:#1F497D;text-decoration:none"><img border="0" width="27" height="26" id="Picture_x0020_4" src="cid:image004.jpg@01D297E0.504D2FF0" alt="Screenshot-2014-07-24-09"></span></a><span style="color:#1F497D"> </span><a href="http://calpsc.org/blog/"><span style="color:blue;text-decoration:none"><img border="0" width="25" height="25" id="Picture_x0020_5" src="cid:image005.png@01D297E0.504D2FF0" alt="RSS smaller"></span></a><span style="color:#1F497D"> </span><a href="https://www.youtube.com/user/CalPSC"><span style="color:#1F497D;text-decoration:none"><img border="0" width="25" height="25" id="Picture_x0020_6" src="cid:image006.png@01D297E0.504D2FF0" alt="youtube-icon smaller"></span></a><span style="color:black"><o:p></o:p></span></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:"Times New Roman",serif">--
<br>
<br>
--- <br>
You received this message because you are subscribed to the Google Groups "CPSC Pharmaceuticals Stewardship Listserv" group.<br>
To unsubscribe from this group and stop receiving emails from it, send an email to
<a href="mailto:cpsc-pharmaceuticals-listserv+unsubscribe@googlegroups.com">cpsc-pharmaceuticals-listserv+unsubscribe@googlegroups.com</a>.<br>
For more options, visit <a href="https://groups.google.com/d/optout">https://groups.google.com/d/optout</a>.<o:p></o:p></span></p>
</div>
</body>
</html>